Old Web
English
Sign In
Acemap
>
Paper
>
175Bleeding and cardiovascular risk of New Oral Anti-Coagulants (NOACs) versus warfarin in type 2 diabetes
175Bleeding and cardiovascular risk of New Oral Anti-Coagulants (NOACs) versus warfarin in type 2 diabetes
2021
Dahai Yu
Julian Brown
David Simmons
Keywords:
Cardiology
Type 2 diabetes
Anti-coagulants
Entropy (energy dispersal)
Blood pressure
Internal medicine
ADRENAL CORTICOSTEROIDS
total cholesterol
Warfarin
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]